Arbutus Biopharma (ABUS) Other Non-Current Assets (2010 - 2026)
Arbutus Biopharma (ABUS) reported Other Non-Current Assets of $132,000 for Q2 2026, up 0.8% from the prior quarter.
Analysis
Arbutus Biopharma (ABUS) Other Non-Current Assets (2010 - 2026) Analysis & Trends
At the end of FY2025, Arbutus Biopharma posted Other Non-Current Assets of $130,000, up 282.4% from FY2024.
- Other Non-Current Assets has a five-year compound annual growth rate of 24.2% (FY2020 to FY2025).
- By year, Other Non-Current Assets came in at $34,000 in FY2024, $103,000 in FY2022 (+68.9%) and $61,000 in FY2021 (+38.6%).
- The Q2 2026 figure ranks as the highest quarterly Other Non-Current Assets since Q3 2022.
- Per Business Quant data, the three quarters before Q2 2026 came in at $131,000 (Q1 2026), $130,000 (Q4 2025) and $131,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,166.70 Bn | 1,135.28 Bn | 19.71 Bn | 7.48 Bn |
| 2 | Johnson & Johnson | 633.99 Bn | 552.52 Bn | 17.26 Bn | 14.27 Bn |
| 3 | AbbVie | 502.96 Bn | 476.07 Bn | 12.70 Bn | 10.73 Bn |
| 4 | Merck | 377.09 Bn | 331.47 Bn | 12.21 Bn | 19.60 Bn |
| 5 | Novartis Ag | 303.78 Bn | 267.77 Bn | 11.24 Bn | 5.93 Bn |
| 6 | Astrazeneca | 266.66 Bn | 240.35 Bn | 12.86 Bn | - |
| 7 | Amgen | 241.39 Bn | 196.79 Bn | 7.24 Bn | 12.98 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | 4.75 Bn |
| 9 | Pfizer | 172.37 Bn | 119.01 Bn | 10.94 Bn | 9.94 Bn |
| 10 | Arbutus Biopharma | 846.16 Mn | 473.14 Mn | - | 132,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 132,000.00 |
| Mar 31, 2026 | 131,000.00 |
| Dec 31, 2025 | 130,000.00 |
| Sep 30, 2025 | 131,000.00 |
| Mar 31, 2025 | 34,000.00 |
| Dec 31, 2024 | 34,000.00 |
| Sep 30, 2023 | 3,000.00 |
| Jun 30, 2023 | 11,000.00 |
| Mar 31, 2023 | 62,000.00 |
| Dec 31, 2022 | 103,000.00 |
| Sep 30, 2022 | 167,000.00 |
| Jun 30, 2022 | 180,000.00 |
| Mar 31, 2022 | 190,000.00 |
| Dec 31, 2021 | 61,000.00 |
| Dec 31, 2020 | 44,000.00 |
| Sep 30, 2020 | 109,000.00 |
| Jun 30, 2020 | 173,000.00 |
| Mar 31, 2020 | 233,000.00 |
| Dec 31, 2019 | 293,000.00 |
| Mar 31, 2015 | -155.87 Mn |
API Access
Arbutus Biopharma Other Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=ABUS&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-assets", "ticker": "ABUS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=ABUS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();